Phio Pharmaceuticals (PHIO)
(Delayed Data from NSDQ)
$0.68 USD
-0.02 (-3.40%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $0.68 0.00 (-0.29%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth F Momentum D VGM
Cash flow Statements
Fiscal Year End for Phio Pharmaceuticals Corp falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -10.83 | -11.48 | -13.29 | -8.79 | -8.91 |
Depreciation/Amortization & Depletion | 0.06 | 0.07 | 0.08 | 0.07 | 0.07 |
Net Change from Assets/Liabilities | -0.54 | -1.26 | 0.99 | -0.33 | -0.21 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 0.56 | 0.54 | 0.36 | 0.25 | 0.41 |
Net Cash From Operating Activities | -10.75 | -12.13 | -11.86 | -8.80 | -8.65 |
Property & Equipment | -0.01 | -0.12 | -0.05 | -0.02 | -0.07 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -0.01 | -0.12 | -0.05 | -0.02 | -0.07 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 7.44 | 0.00 | 21.72 | 15.93 | 0.78 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.20 | -0.01 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -0.03 | -0.03 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 7.41 | -0.03 | 21.72 | 16.13 | 0.77 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -3.34 | -12.28 | 9.81 | 7.31 | -7.95 |
Cash at Beginning of Period | 11.83 | 24.11 | 14.29 | 6.98 | 14.93 |
Cash at End of Period | 8.49 | 11.83 | 24.11 | 14.29 | 6.98 |
Diluted Net EPS | -5.20 | -10.10 | -12.48 | -23.05 | -232.05 |
Fiscal Year End for Phio Pharmaceuticals Corp falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -10.83 | -8.93 | -6.15 | -3.60 |
Depreciation/Amortization & Depletion | NA | 0.06 | 0.05 | 0.03 | 0.02 |
Net Change from Assets/Liabilities | NA | -0.54 | 0.12 | 0.37 | 0.74 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 0.56 | 0.39 | 0.27 | 0.14 |
Net Cash From Operating Activities | NA | -10.75 | -8.38 | -5.48 | -2.71 |
Property & Equipment | NA | -0.01 | -0.01 | -0.01 | 0.00 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | -0.01 | -0.01 | -0.01 | 0.00 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 7.44 | 5.04 | 5.04 | -0.01 |
Issuance (Repayment) of Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | -0.03 | -0.03 | -0.03 | -0.03 |
Net Cash from Financing Activities | NA | 7.41 | 5.01 | 5.01 | -0.04 |
Effect of Exchange Rate Changes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | NA | -3.34 | -3.37 | -0.47 | -2.75 |
Cash at Beginning of Period | NA | 11.83 | 11.83 | 11.83 | 11.83 |
Cash at End of Period | NA | 8.49 | 8.46 | 11.36 | 9.09 |
Diluted Net EPS | NA | 0.56 | -1.14 | -1.47 | -3.15 |